Cargando…
RACO‐1 modulates Hippo signalling in oesophageal squamous cell carcinoma
Oesophageal cancer is one of the most lethal malignancies worldwide, whereas the 5‐year survival is less than 20%. Although the detailed carcinogenic mechanisms are not totally clear, recent genomic sequencing data showed dysregulation of Hippo signalling could be a critical factor for oesophageal s...
Autores principales: | Pang, Dan, Wang, Weilong, Zhou, Xiaofeng, Lu, Kui, Zhang, Jinghang, Chen, Zhiguo, Wang, Lingchao, Shen, Fangfang, Chen, Zhen, Wang, Sujie, Hou, Jinghan, Zhang, Aijia, Lv, Benjie, Gao, Can, Yan, Ziyi, Hu, Yuhan, Chang, Tingmin, Wang, Lidong, Li, Xiumin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579699/ https://www.ncbi.nlm.nih.gov/pubmed/32896069 http://dx.doi.org/10.1111/jcmm.15811 |
Ejemplares similares
-
SHARPIN Inhibits Esophageal Squamous Cell Carcinoma Progression by Modulating Hippo Signaling
por: Zhang, Aijia, et al.
Publicado: (2019) -
Regulation of Hippo/YAP signaling and Esophageal Squamous Carcinoma progression by an E3 ubiquitin ligase PARK2
por: Zhou, Xiaofeng, et al.
Publicado: (2020) -
RNF168 facilitates proliferation and invasion of esophageal carcinoma, possibly via stabilizing STAT1
por: Yu, Na, et al.
Publicado: (2018) -
Prognostic value of increased expression of RACO-1 in patients with hepatitis B-related hepatocellular carcinoma
por: Chen, Jian-yao, et al.
Publicado: (2017) -
Copeptin adaptive response to SGLT2 inhibitors in patients with type 2 diabetes mellitus: The GliRACo study
por: Berton, Alessandro Maria, et al.
Publicado: (2023)